J. Jefferson Smith - Net Worth and Insider Trading
J. Jefferson Smith Net Worth
The estimated net worth of J. Jefferson Smith is at least $634,102 dollars as of 2024-11-05. J. Jefferson Smith is the Chief Research Officer of Precision BioSciences Inc and owns about 76,490 shares of Precision BioSciences Inc (DTIL) stock worth over $634,102. Details can be seen in J. Jefferson Smith's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that J. Jefferson Smith has not made any transactions after 2024-06-10 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of J. Jefferson Smith
J. Jefferson Smith Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, J. Jefferson Smith owns 1 companies in total, including Precision BioSciences Inc (DTIL) .
Click here to see the complete history of J. Jefferson Smith’s form 4 insider trades.
Insider Ownership Summary of J. Jefferson Smith
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| DTIL | Precision BioSciences Inc | 2024-06-10 | 10 percent owner |
J. Jefferson Smith Latest Holdings Summary
J. Jefferson Smith currently owns a total of 1 stock. J. Jefferson Smith owns 76,490 shares of Precision BioSciences Inc (DTIL) as of June 10, 2024, with a value of $634,102.
Latest Holdings of J. Jefferson Smith
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| DTIL | Precision BioSciences Inc | 2024-06-10 | 76,490 | 8.29 | 634,102 |
Holding Weightings of J. Jefferson Smith
J. Jefferson Smith Form 4 Trading Tracker
According to the SEC Form 4 filings, J. Jefferson Smith has made a total of 3 transactions in Precision BioSciences Inc (DTIL) over the past 5 years, including 0 buys and 3 sells. The most-recent trade in Precision BioSciences Inc is the sale of 50 shares on June 10, 2024, which brought J. Jefferson Smith around $590.
Insider Trading History of J. Jefferson Smith
- 1
J. Jefferson Smith Trading Performance
J. Jefferson Smith Ownership Network
Ownership Network List of J. Jefferson Smith
Ownership Network Relation of J. Jefferson Smith
J. Jefferson Smith Owned Company Details
What does Precision BioSciences Inc do?
Who are the key executives at Precision BioSciences Inc?
J. Jefferson Smith is the 10 percent owner of Precision BioSciences Inc. Other key executives at Precision BioSciences Inc include General Counsel Dario Scimeca , Chief Medical Officer Alan List , and director & President and CEO Michael Amoroso .
Precision BioSciences Inc (DTIL) Insider Trades Summary
Over the past 18 months, J. Jefferson Smith made 3 insider transaction in Precision BioSciences Inc (DTIL) with a net sale of 28,204. Other recent insider transactions involving Precision BioSciences Inc (DTIL) include a net sale of 51,036 shares made by Dario Scimeca , a net sale of 263,941 shares made by Michael Amoroso , and a net sale of 22,054 shares made by Alan List .
In summary, during the past 3 months, insiders sold 0 shares of Precision BioSciences Inc (DTIL) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 14,710 shares of Precision BioSciences Inc (DTIL) were sold and 3,000 shares were bought by its insiders, resulting in a net sale of 11,710 shares.
Precision BioSciences Inc (DTIL)'s detailed insider trading history can be found in Insider Trading Tracker table.
Precision BioSciences Inc Insider Transactions
J. Jefferson Smith Mailing Address
Above is the net worth, insider trading, and ownership report for J. Jefferson Smith. You might contact J. Jefferson Smith via mailing address: C/o Precision Biosciences, Inc., 302 East Pettigrew Street, Suite A-100, Durham Nc 27701.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
